In 2018, the company set out to develop a new disposable pen injector platform for medicines such as those used to treat diabetes. Reducing the device’s carbon footprint was a key priority, especially given the high production volumes. The switch to Bormed resins helped Nemera meet its safety and environmental targets without compromising on performance or production efficiency. ****Come see the injector pen sample at K Fair, October 8-15, 2025, and discover how Bormed is shaping the future of chronic care treatments. Medical polyolefins in the Bormed™ grade portfolio offer superior technical performance, fulfilling the most stringent requirements in terms of safety and quality.